Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Brainimmune is Looking for a Strategic Partner to Advance the Neuroendocrine Immunology and Stress-Immunity Research Field
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
Neuroendocrine Phenotypes that Affect Immune Responses in Mammals Found in Avian SpeciesOctober 15, 2021
Identification of GM-SCF as possible distinctive blood marker predicting severe COVID-19March 23, 2021
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe CasesFebruary 6, 2021
Production of immunomodulatory and anti-inflammatory neuropeptides by specific gut microbiota genera: in silico evidenceMay 7, 2019
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK CellsFebruary 18, 2021
First Evidence that Catecholamines Inhibit IL-27 Production by Antigen Presenting CellsJanuary 6, 2018
A Sympathetic-Adrenal Neuroimmune Reflex Linked to the Immunosuppressive Effects of Spinal Cord InjuryOctober 30, 2017
